Document is current
Any future updates will be listed below
-
Authors
Dyer, Rebekah P.
Isoda, Hariny M.
Salcedo, Gabriela S.
Speciale, Gaetano
Fletcher, Madison H.
Le, Linh Q.
Liu, Yi
Brami-Cherrier, Karen
Malik, Shiazah Z.
Vazquez-Cintron, Edwin J.
Chu, Andrew C.
Rupp, David C.
Jacky, Birgitte P. S.
Nguyen, Thu T. M.
Katz, Benjamin B.
Steward, Lance E.
Majumdar, Sudipta
Brideau-Andersen, Amy D.
Weiss, Gregory A.
-
Funding
Funding for this research was provided by:
Allergan
- License Information
-
More Information
Article History
Received: 20 October 2021
Accepted: 17 May 2022
First Online: 15 June 2022
Competing interests
: L.Q.L., S.L., K.B.-C., S.Z.M., E.J.V.-C., D.C.R., B.P.S.J., L.E.S., and A.D.B.-A. are full-time employees of AbbVie and receive salary and/or stocks/stock options as compensation. G.A.W., A.D.B.-A., R.P.D., L.E.S., L.Q.L., G.S., D.C.R., B.P.S.J., M.H.F., and S.M. are inventors on a related provisional patent application. All other authors declare that they have no competing interests.
